Does This Side Effect Spell Doom for the GLP-1s?

bir ses eklendi EĞİTİM BİLGİLERİ

2025-08-19 06:28:42 - Translate -

GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro have taken the world by storm. Initially approved for type 2 diabetes, they quickly became household names for their impressive weight-loss effects. Backed by celebrity endorsements and millions of success stories, these medications promised not just slimmer bodies, but longer, healthier lives. But a growing number of adverse event...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme